Table 6d. KEGG pathways enriched for mRNAs predicted to be targeted by miRNAs listed in Table 6c.
| KEGG PATHWAY | P value | # genes | # miRNAs |
|---|---|---|---|
| MAPK signaling pathway | 1.37e-41 | 135 | 34 |
| PI3K-Akt signaling pathway | 1.43e-40 | 168 | 33 |
| Focal adhesion | 3.05e-31 | 104 | 31 |
| Wnt signaling pathway | 5.92e-29 | 89 | 28 |
| Axon guidance | 6.27e-27 | 78 | 33 |
| Pathways in cancer | 4.06e-25 | 170 | 34 |
| Dopaminergic synapse | 6.08e-25 | 78 | 35 |
| Ubiquitin mediated proteolysis | 8.91e-24 | 77 | 31 |
| Neurotrophin signaling pathway | 2.71e-22 | 72 | 32 |
| Glioma | 5.01e-20 | 44 | 25 |
| ErbB signaling pathway | 1.61e-18 | 57 | 31 |
| TGF-beta signaling pathway | 1.94e-18 | 51 | 27 |
The number of genes targeted in each pathway and the number of miRNAs predicted to target those mRNAs are indicated in the third and fourth column, respectively. The significance level is indicated by a corrected p-value